Filing metadata

Accession number
0000950170-24-045696
Form type
Form 4
Filer
Amylyx Pharmaceuticals, Inc.
CIK
CIK 1658551
Filed
Apr 18, 2024
Reporting period
Apr 16, 2024
Description
Insider transaction

Explore SEC Filings Hub

4 | SEC Filings Hub